myelodysplastic syndrome
CareDx to Conduct Pharmacokinetic Testing in TC BioPharm's AML, MDS Cell Therapy Trial
CareDx will use its sequencing-based AlloCell assay to assess the duration and effect of TC BioPharm's candidate blood cancer therapy on the immune system.
National Cancer Institute Launches MyeloMATCH Myeloid Cancer Treatment Clinical Trial
The trial aims to enroll several thousand patients to test precision medicine treatments for bone marrow and blood cancers.
Abbott PCR Test Gets FDA Approval as CDx for Servier's Tibsovo for Rare Blood Cancer
The drug and test were approved for patients with relapsed or refractory myelodysplastic syndromes.
The high-coverage whole-genome assay is covered for patients with myeloid neoplasms, including acute myeloid leukemia and myelodysplastic syndrome.
MD Anderson Cancer Center researchers demonstrated the prognostication utility of optical genome mapping in myelodysplastic syndromes patients.